Overview

  • Product nameQX-222
  • Description
    Na+ channel blocker
  • Biological descriptionNa+ channel blocker. Lidocaine derivative.
  • Purity> 99%

Properties

    References for QX-222 (ab120126)

    This product has been referenced in:
    • Undrovinas AI & Makielski JC Blockade of lysophosphatidylcholine-modified cardiac Na channels by a lidocaine derivative QX-222. Am J Physiol 271:H790-7 (1996). Read more (PubMed: 8770124) »
    • Puil E & Carlen PL Attenuation of glutamate-action, excitatory postsynaptic potentials, and spikes by intracellular QX 222 in hippocampal neurons. Neuroscience 11:389-98 (1984). Read more (PubMed: 6144079) »

    See 0 Publications for this product

    Product Wall

    There are currently no Questions for ab120126.
    Please use the link above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"